|
시장보고서
상품코드
2076066
세포 투과 펩티드 시장 : 유형별, 용도별, 최종 사용자별, 지역별Global Cell Penetrating Peptide Market, By Type, By Application, By End User, By Geography |
||||||
세계의 세포 투과 펩티드 시장은 2026년에 49억 달러로 추정되고 있어 2033년까지 143억 5,000만 달러에 이를 전망입니다. 2026년부터 2033년까지 CAGR 16.6%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 49억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 16.60% | 2033년 시장 규모 예측 : | 143억 5,000만 달러 |
세포 투과 펩티드(CPP)는 세포막을 통과하여 항체, 핵산, 항암제 등과 결합된 생물학적 활성 물질을 세포 내부로 전달할 수 있는 짧은 아미노산 서열입니다. 이러한 장벽을 횡단하는 능력 덕분에 CPP는 중요한 분자 전달체로 자리매김하여, 다양한 임상시험용 의약품 및 승인된 치료제의 전달을 가능하게 하고 있습니다. 이 분야에서는 안정성, 용해성, 세포 내 흡수 효율과 같은 약리학적 특성을 향상시키기 위해, 세포 투과 펩티드(CPP)의 서열 및 결합 기술 최적화에 관한 연구가 활발히 진행되고 있습니다. 암, 신경퇴행성 질환, 만성 감염증 등의 질환에 대한 CPP 기반 전달 전략 개발에 대한 관심이 높아지는 가운데, 세포 투과 펩티드 시장은 향후 급속한 성장이 예상됩니다.
CPP는 생리학적 조건 하에서 표적 분자를 살아있는 세포에 비침습적이고 효율적이며 신속하게 전달할 수 있기 때문에 기존의 형질 도입법에 비해 여러 가지 장점이 있습니다. 분자 결합이 용이하고 생체 적합성이 높은 전달이 가능하기 때문에 CPP는 단백질 치료, 유전자 전달, 진단용 영상 등을 포함한 연구 및 치료 응용 분야에서 헤아릴 수 없는 가능성을 지니고 있습니다. 그러나 비선택적인 이중층 파괴나 고농도에서의 세포 독성 가능성은 여전히 큰 과제로 남아 있습니다. 개선된 설계 전략은 더 안전하고 표적 특이성이 높은 CPP의 개발을 목표로 하고 있습니다.
시장 역학:
세포 투과 펩티드 시장은 암 및 기타 치료제의 세포 내 전달이 필요한 질환의 발생률 증가, 연구 개발 활성화, 제약 기업의 투자, 그리고 펩티드계 의약품의 채택 확대에 힘입어 성장하고 있습니다. 그러나 일부 CPP에 수반되는 낮은 안정성, 예측 불가능한 독성, 그리고 면역 반응 억제 등의 문제가 시장 성장을 저해하고 있습니다. 무독성이며 생체적합성이 높은 차세대 펩티드 서열을 개발하기 위한 연구가 진행 중이며, 이는 큰 성장 기회를 가져다주고 있습니다.
따라서, 암 유병률 증가가 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 미국 암 협회가 2021년에 발표한 자료에 따르면, 미국의 ‘암에 관한 사실과 수치”에서는 2021년 미국의 암 환자 수 추정치가 다음과 같이 보고되어 있습니다.
2021년 미국 내 암 신규 추정 환자 수.
여성의 유방암.
폐·기관지암.
피부 악성 흑색종.
방광암.
전립선암.
결장·직장.
자궁.
자궁경부.
자궁.
자궁체부.
백혈병.
비호지킨.
림프종.
281,550.
235,760.
106,110.
83,730.
248,530.
149,500.
281,550.
149,500.
61,090.
81,560.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 세포 투과 펩티드 시장의 주요 기업 프로파일을 소개했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계 세포 투과 펩티드 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 세포 투과성 펩티드 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 세포 투과 펩티드 시장 : 유형별, 2021-2033년
제5장 세계의 세포 투과 펩티드 시장 : 용도별, 2021-2033년
제6장 세계의 세포 투과 펩티드 시장 : 최종 사용자별, 2021-2033년
제7장 세계의 세포 투과 펩티드 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
JHS 26.07.09Global Cell Penetrating Peptide Market is estimated to be valued at USD 4.90 Bn in 2026 and is expected to reach USD 14.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.90 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 16.60% | 2033 Value Projection: | USD 14.35 Bn |
Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.
CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.
Market Dynamics:
The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.
Thus, the increasing prevalence of cancer is expected to propel market growth over the forecast period. For instance, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below:
ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021
Female Breast Cancer
Lung & bronchus
Melanoma of the skin
Urinary bladder
Prostate
Colon & rectum
Uterine
cervix
Uterine
corpus
Leukemia
Non Hodgkin
lymphoma
281,550
235,760
106,110
83,730
248,530
149,500
281,550
149,500
61,090
81,560
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market
Detailed Segmentation:
- Global Cell Penetrating Peptide Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Protein Derived CPPs
- Synthetic CPPs
- Chimeric CPPs
- Global Cell Penetrating Peptide Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Others
- Global Cell Penetrating Peptide Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical Companies
- Contract Research Organization (CROs)/CDMO
- Hospitals and Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Cell Penetrating Peptide Market, Key Players
- AnaSpec
- Peptomyc
- BioAlps
- Sarepta Therapeutics, Inc.
- REVANCE THERAPEUTICS
- PolyPeptide Group
- Bachem
- Pepscan
- Creative Peptides
- Cupidpeptides
- AltaBioscience Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cell Penetrating Peptide Market, By Type
- Global Cell Penetrating Peptide Market, By Application
- Global Cell Penetrating Peptide Market, By End User
- Global Cell Penetrating Peptide Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Expanding Applications in Regenerative Medicine
- Low drug encapsulation efficiency
- Increasing applications of CPPs in therapeutics development
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Cell Penetrating Peptide Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Protein Derived CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Synthetic CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Chimeric CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Cell Penetrating Peptide Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Molecular Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Cell Penetrating Peptide Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Research Organization (CROs)/CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Cell Penetrating Peptide Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- AnaSpec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Peptomyc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioAlps
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- REVANCE THERAPEUTICS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- Bachem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pepscan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Creative Peptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cupidpeptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AltaBioscience Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
